Compassionate Use of Ubamatamab

NCT07502716 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Renal Medullary Carcinoma (RMC)
Epithelioid Sarcoma

Interventions

DRUG: ubamatamab

Sponsor

Regeneron Pharmaceuticals